Alpha cognition to report second quarter 2025 financial results and operating overview

Vancouver, british columbia & dallas--(business wire)--alpha cognition inc. (nasdaq: acog), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced that it will release financial results for the second quarter on august 14, 2025 after close of market. following the release, management will host a conference call to review financial and operating results. conference call information: to participate in the conference call, please use the dial-.
ACOG Ratings Summary
ACOG Quant Ranking